Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
EBIT Margin

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year EBIT Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Margin(%) 9.6213.0516.2712.424.95

What is the latest EBIT Margin ratio of INDOCO REMEDIES ?

The latest EBIT Margin ratio of INDOCO REMEDIES is 9.62 based on Mar2024 Consolidated results.
Year EBIT Margin
Mar20249.62
Mar202313.05
Mar202216.27
Mar202112.42
Mar20204.95

How is EBIT Margin of INDOCO REMEDIES Trending?

Years EBIT Margin % Change
Mar2024 9.62
-26.28
Mar2023 13.05
-19.79
Mar2022 16.27
31.00
Mar2021 12.42
150.91
Mar2020 4.95 -

Other Financial Ratios of INDOCO REMEDIES


Compare EBIT Margin ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,999.7 Cr -3.8% -3.3% -14% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,382.0 Cr -5.8% -3.2% 35.1% Stock Analytics
DIVIS LABORATORIES ₹159,224.0 Cr -2.8% -3.6% 44.7% Stock Analytics
CIPLA ₹116,943.0 Cr -3.9% -0.5% 13.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,588.0 Cr -1.2% 7.1% 17.8% Stock Analytics
ZYDUS LIFESCIENCES ₹100,704.0 Cr -2.7% -0.1% 40.9% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-3.8%

-3.3%

-14%

SENSEX

-2.2%

-5.9%

7.2%


You may also like the below Video Courses